Entity Common Stock, Shares Outstanding of TherapeuticsMD, Inc. from 07 Nov 2011 to 11 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
TherapeuticsMD, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 07 Nov 2011 to 11 Nov 2025.
  • TherapeuticsMD, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 11 Nov 2025 was 11,574,362.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

TherapeuticsMD, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 11,574,362 11 Nov 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 11,574,362 +41,930 +0.36% 06 Aug 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 11,574,362 +41,919 +0.36% 20 Mar 2025 10-K 27 Mar 2025 2024 FY
Q2 2024 11,532,432 +957,192 +9.1% 12 Aug 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 11,532,443 +1,579,153 +16% 27 Mar 2024 10-K 29 Mar 2024 2023 FY
Q3 2023 10,575,240 +1,108,136 +12% 14 Nov 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 10,575,240 +1,150,348 +12% 09 Aug 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 9,953,290 -423,474,588 -98% 05 Apr 2023 10-K 07 Apr 2023 2022 FY
Q3 2022 9,467,104 -415,461,566 -98% 11 Nov 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 9,424,892 -414,392,434 -98% 08 Aug 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 433,427,878 +45,602,333 +12% 17 Mar 2022 10-K 23 Mar 2022 2021 FY
Q3 2021 424,928,670 +152,116,399 +56% 11 Nov 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 423,817,326 +151,522,946 +56% 04 Aug 2021 10-Q 04 Aug 2021 2021 Q2
Q1 2021 387,825,545 +116,142,279 +43% 01 Mar 2021 10-K 04 Mar 2021 2020 FY
Q3 2020 272,812,271 +1,635,195 +0.6% 02 Nov 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 272,294,380 -240,949,545,620 03 Aug 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 271,683,266 +30,461,426 +13% 20 Apr 2020 10-K/A 29 Apr 2020 2019 FY
Q3 2019 271,177,076 +33,295,887 +14% 04 Nov 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 241,221,840,000* +241,005,005,941 02 Aug 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 241,221,840 +24,637,566 +11% 01 May 2019 10-Q 08 May 2019 2019 Q1
Q3 2018 237,881,189 +21,451,547 +9.9% 01 Nov 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 216,834,059 +12,806,917 +6.3% 23 Jul 2018 10-Q 30 Jul 2018 2018 Q2
Q1 2018 216,584,274 +12,657,132 +6.2% 30 Apr 2018 10-Q 07 May 2018 2018 Q1
Q3 2017 216,429,642 +19,849,430 +10% 30 Oct 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 204,027,142 +7,534,947 +3.8% 31 Jul 2017 10-Q 03 Aug 2017 2017 Q2
Q1 2017 203,927,142 +7,663,442 +3.9% 27 Apr 2017 10-Q 03 May 2017 2017 Q1
Q3 2016 196,580,212 +18,732,171 +11% 31 Oct 2016 10-Q 04 Nov 2016 2016 Q3
Q2 2016 196,492,195 +18,991,465 +11% 01 Aug 2016 10-Q 05 Aug 2016 2016 Q2
Q1 2016 196,263,700 +24,548,149 +14% 02 May 2016 10-Q 05 May 2016 2016 Q1
Q3 2015 177,848,041 +21,817,565 +14% 02 Nov 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 177,500,730 +21,692,965 +14% 03 Aug 2015 10-Q 07 Aug 2015 2015 Q2
Q1 2015 171,715,551 +26,698,491 +18% 06 Mar 2015 10-K 12 Mar 2015 2014 FY
Q3 2014 156,030,476 +11,062,469 +7.6% 04 Nov 2014 10-Q 07 Nov 2014 2014 Q3
Q2 2014 155,807,765 +24,595,059 +19% 04 Aug 2014 10-Q 07 Aug 2014 2014 Q2
Q1 2014 145,017,060 +45,232,078 +45% 03 Mar 2014 10-K 05 Mar 2014 2013 FY
Q3 2013 144,968,007 +45,183,025 +45% 04 Nov 2013 10-Q 05 Nov 2013 2013 Q3
Q2 2013 131,212,706 +35,462,494 +37% 07 Aug 2013 10-Q 07 Aug 2013 2013 Q2
Q1 2013 99,784,982 +15,176,156 +18% 28 Feb 2013 10-K 12 Mar 2013 2012 FY
Q3 2012 99,784,982 +18,580,216 +23% 30 Sep 2012 10-Q 13 Nov 2012 2012 Q3
Q2 2012 95,750,212 30 Jun 2012 10-Q 09 Aug 2012 2012 Q2
Q1 2012 84,608,826 23 Mar 2012 10-K 27 Mar 2012 2011 FY
Q4 2011 82,978,804 31 Dec 2011 10-Q 13 Nov 2012 2012 Q3
Q3 2011 81,204,766 07 Nov 2011 10-Q 07 Nov 2011 2011 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.